Tetsuya Isaka

13PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2025
Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasis.

Tetsuya Isaka, Yohei Miyagi, Rika Kasajima

|Jun 27, 2025
A multi-institutional randomized phase III trial of lobectomy versus segmentectomy for radiologically solid-predominant non-small cell lung cancer with a ground-glass opacity and tumor diameter > 2 cm and ≤ 3 cm: JCOG2217 (STRONG).

Noriko Mitome, Aritoshi Hattori, Kenji Suzuki

|Mar 04, 2025
Comparison of the Changes in Visceral Adipose Tissue After Lobectomy and Segmentectomy for Patients With Early-Stage Lung Cancer.

Tetsuya Isaka, Takuya Nagashima, Kota Washimi

|May 03, 2024
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.

Naoko Shigeta, Shuji Murakami, Tomoyuki Yokose

|Feb 23, 2024
Right S3 segmentectomy for lung cancer with partial anomalous pulmonary venous return in the right upper pulmonary vein: A case report.

Tetsuya Isaka, Takuya Nagashima, Kotaro Murakami

|Jan 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".

Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami

Pageof 3

Frequent Collaborators

3 joint publications

Hiroyuki Ito

3 joint publications

Kenji Suzuki

3 joint publications

Naoko Shigeta

2 joint publications

Tomoyuki Yokose